Existing clinical trials for Psychedelic-Assisted Psychotherapy (PAP) often have limited external validity because they enroll only 3–6% of screened patients, typically excluding those with suicidality and comorbidity.

Authors

• Person: Not available Organization: Frontiers in Psychiatry
  The Montreal model: an integrative biomedical-psychedelic ...

Sources

• The Montreal model: an integrative biomedical-psychedelic ... www.frontiersin.org Frontiers in Psychiatry via serper

Referenced by nodes (2)

• psychedelic-assisted psychotherapy concept
• suicidality concept